Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Burns ; 50(3): 630-640, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37980271

RESUMO

BACKGROUND: Magnesium (Mg) is an essential factor in the healing process. This study aimed to evaluate the effect of Mg creams on healing burn wounds in the rat model. METHODS: To induce burns under general anaesthesia, a 2 × 2 cm2, 100 °C plate was placed for 12 s between the scapulas in 100 male adult Sprague Dawley rats. Animals were divided into five groups (n = 20); positive control (induced burn without treatment); vehicle control (received daily Eucerin cream base topically); comparative control (induced burn and treated daily with Alpha burn cream topically); Treatment 1 and 2 (received daily Mg cream 2% and 4% topically, respectively). All animals were bled for hematological assessment of malondialdehyde (MDA) and TNF-α and sacrificed on days 0, 1, 7, 14, and 21 after interventions for biomechanical, histological, and stereological studies. RESULTS: Stereologically speaking, in treatment groups an increase in dermal collagen volume and fibroblasts was noticed. In treatment groups, the length of vessels, angiogenesis, and skin stretch increased, but the wound area, MDA, and TNF-α level decreased. CONCLUSION: Mg cream was effective in healing burns.


Assuntos
Queimaduras , Magnésio , Ratos , Masculino , Animais , Magnésio/uso terapêutico , Fator de Necrose Tumoral alfa , Queimaduras/tratamento farmacológico , Queimaduras/patologia , Ratos Sprague-Dawley , Cicatrização
3.
Int J Hypertens ; 2022: 5937802, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35075396

RESUMO

Hypertension is a major risk factor for cardiovascular disease. Previous studies showed that patients with hypertension are at an increased risk of developing severe COVID-19 infection. Therefore, proper blood pressure control in hypertensive patients with COVID-19 is of great importance. In this review, we discussed the effects of different classes of antihypertensive drugs on patients with hypertension and COVID-19.

4.
Mediators Inflamm ; 2021: 5578568, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34335090

RESUMO

Lichen planus is considered a chronic inflammatory disease which affects different sites, such as the skin, mucous membranes, hair, and nails. Based on the evidence, a complex cytokine network plays a crucial role in lichen planus pathogenesis. The study was aimed at assessing the serum IL-23 levels in the patients with cutaneous and oral lichen planus compared to healthy controls. Method. The study included 30 cutaneous lichen planus patients, 20 oral lichen planus patients, and 33 control subjects. Five milliliters of peripheral blood was obtained from each patient, and the serum was separated. IL-23 levels were determined using the ELISA kit, and the data were analyzed using the Mann-Whitney test. Results. IL-23 levels in the patient serum with oral lichen planus (P value ≤ 0.001) were significantly higher than in controls. Furthermore, there were significant differences in IL-23 serum levels in the patients with cutaneous lichen planus compared to the healthy controls (P value ≤ 0.001). Moreover, IL-23 serum levels were statistically different between patients with cutaneous lichen planus and patients with oral lichen planus (P value ≤ 0.001). Based on the mean concentration of interleukin-23, IL-23 levels were higher in the patients with oral lichen planus than in the patients with cutaneous lichen planus. Conclusions. Elevated serum IL-23 levels in the patients with oral lichen planus may indicate that IL-23 plays a crucial role in the pathogenesis of oral lichen planus. However, more research is needed with a larger sample size.


Assuntos
Subunidade p19 da Interleucina-23/sangue , Líquen Plano Bucal , Líquen Plano , Humanos , Interleucina-23 , Líquen Plano/patologia , Líquen Plano Bucal/patologia , Pele/patologia
5.
Parasitol Res ; 120(4): 1151-1166, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33534053

RESUMO

The mechanistic (or mammalian) target of rapamycin (mTOR) is considered as a critical regulatory enzyme involved in essential signaling pathways affecting cell growth, cell proliferation, protein translation, regulation of cellular metabolism, and cytoskeletal structure. Also, mTOR signaling has crucial roles in cell homeostasis via processes such as autophagy. Autophagy prevents many pathogen infections and is involved on immunosurveillance and pathogenesis. Immune responses and autophagy are therefore key host responses and both are linked by complex mTOR regulatory mechanisms. In recent years, the mTOR pathway has been highlighted in different diseases such as diabetes, cancer, and infectious and parasitic diseases including leishmaniasis, toxoplasmosis, and malaria. The current review underlines the implications of mTOR signals and intricate networks on pathogen infections and the modulation of this master regulator by parasites. Parasitic infections are able to induce dynamic metabolic reprogramming leading to mTOR alterations in spite of many other ways impacting this regulatory network. Accordingly, the identification of parasite effects and interactions over such a complex modulation might reveal novel information regarding the biology of the abovementioned parasites and might allow the development of therapeutic strategies against parasitic diseases. In this sense, the effects of inhibiting the mTOR pathways are also considered in this context in the light of their potential for the prevention and treatment of parasitic diseases.


Assuntos
Parasitos/efeitos dos fármacos , Doenças Parasitárias/tratamento farmacológico , Transdução de Sinais/efeitos dos fármacos , Sirolimo/farmacologia , Serina-Treonina Quinases TOR/antagonistas & inibidores , Animais , Autofagia , Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Humanos , Imunidade/efeitos dos fármacos , Leishmaniose/tratamento farmacológico , Leishmaniose/parasitologia , Leishmaniose/prevenção & controle , Malária/tratamento farmacológico , Malária/parasitologia , Malária/prevenção & controle , Parasitos/fisiologia , Doenças Parasitárias/parasitologia , Doenças Parasitárias/prevenção & controle , Fosforilação , Biossíntese de Proteínas/efeitos dos fármacos , Serina-Treonina Quinases TOR/genética , Toxoplasmose/tratamento farmacológico , Toxoplasmose/parasitologia , Toxoplasmose/prevenção & controle
6.
J Dent (Shiraz) ; 21(4): 330-334, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33344684

RESUMO

STATEMENT OF THE PROBLEM: Lichen planus disease is a chronic inflammatory disorder of mucosal and cutaneous tissues with yet unclear etiology and pathogenesis. Cytokines play an important role in the initiation, maintenance of inflammatory and intercellular crosstalk. PURPOSE: We assessed serum levels of IL-22 in patients with oral and cutaneous lichen planus and made comparison with healthy individuals. MATERIALS AND METHOD: In this case-control study, peripheral blood samples of 40 patients with lichen planus disease, included two groups of oral lichen planus (n=20) and cutaneous lichen planus (n=20) were compared with 32 healthy individuals in this case-control study. Serum samples were prepared from patients with lichen planus and IL-22 concentration was measured in each serum sample by using a commercial ELISA Kit. The obtained data were then analyzed using the Kruskal-Wallis (one-way ANOVA) test. RESULTS: The IL-22 serum levels were significantly higher in patients with oral lichen planus compared to the healthy control group (p< 0.001). No statistically significant differences were observed in serum levels of IL-22 in cutaneous lichen planus patients compared to the controls (p= 0.183). CONCLUSION: Increased IL-22 serum levels in patients with oral lichen planus may play an important role in the pathogenesis of oral lichen planus. The administration of the recombinant or antagonist of IL-22 could be a new therapeutic opportunity in the treatment of oral lichen planus.

7.
Health Qual Life Outcomes ; 18(1): 20, 2020 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-32013982

RESUMO

INTRODUCTION: Vitiligo is caused by partial or complete destruction of melanocytes in the affected skin area and influences the patient's quality of life. Besides physical involvement, vitiligo patients experience a high level of stress. Depression and Anxiety are common psychiatric disorders in vitiligo patients. AIM: This study, as the first study, evaluates hopelessness, anxiety, depression and general health of vitiligo patients in comparison with normal controls in an Iranian population. METHOD: Hundred patients with vitiligo and hundred healthy controls were examined. General health, depression, hopelessness and anxiety were evaluated based on general health questionnaire. Anxiety, depression and hopelessness levels were analyzed using Chi-Square, and the mean value of general health was evaluated through t-test. RESULTS: The results showed that anxiety and hopelessness levels were significantly higher in vitiligo patients than those who are in healthy controls. This significant difference refers to high levels of anxiety and hopelessness among women with vitiligo. It was also found that the single patients were more anxious, hopeless and depressive, while the married patients were only more anxious and hopeless than those who are in the control group, respectively. General health of patients was significantly worse than in healthy controls. The low level of general health in patients was related to poorer level of general health among women with vitiligo. CONCLUSION: It seems that women with vitiligo are more mentally stressed than men with vitiligo. Both singles and married vitiligo patients suffer from anxiety and hopelessness.


Assuntos
Qualidade de Vida/psicologia , Vitiligo/psicologia , Adolescente , Adulto , Distribuição por Idade , Ansiedade/complicações , Ansiedade/psicologia , Estudos de Casos e Controles , Depressão/complicações , Depressão/psicologia , Feminino , Esperança , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Prevalência , Distribuição por Sexo , Vitiligo/complicações
8.
Iran J Med Sci ; 42(5): 488-492, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29234182

RESUMO

Pentavalent antimonials, as the 1st choice for the treatment of cutaneous leishmaniasis (CL), have various side effects. Also, there are some reports of drug resistance. Due to its safety, cryotherapy can be a good alternative or complementary treatment in CL. The aim of this study was to explore the possible systemic immunological mechanisms of cryotherapy besides its local effects in the treatment of CL. Twenty patients with CL were selected. The disease was confirmed via a direct smear. A venous blood sample was collected to determine IL-10 and IFN-γ levels before starting cryotherapy. Then, 1 week after 8 sessions of cryotherapy were completed (i.e., 63 d), a 2nd venous sample was taken in order to compare the results with the pretreatment levels of these cytokines using the ELISA method. Cryotherapy resulted in no change in the levels of IL-10 and significantly increased the IFN-γ levels in our patients with CL. Given these inconclusive or even mixed results, a larger sample size is needed in order to better assess the systemic immunological effects of cryotherapy.

9.
PLoS Negl Trop Dis ; 11(10): e0005957, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28981503

RESUMO

BACKGROUND: Cutaneous leishmaniasis is one of the highly prevalent endemic diseases in the Middle East and North Africa. Many treatment modalities have been recommended for this condition but success rates remain limited. Herbal remedies have also been used for treatment but evidence-based clinical trials with these products are sparse. In-vitro and in-vivo studies have shown the anti-leishmanial and curative effects of extract of fruits and leaves of Juniperus excelsa (J. excelsa). The aim of this study was to determine the efficacy of topical J. excelsa M. Bieb extract as an adjuvant to cryotherapy for the treatment of human CL. MATERIALS AND METHODS: This study was designed as a two-arm triple-blind randomized placebo-controlled clinical trial using a parallel design. Seventy-two patients with clinical diagnosis of CL confirmed by leishmania smears were allocated to receive either a topical formulation of leaf of J. excelsa extract (group A) or placebo (group B) for 3 months. Both groups received cryotherapy as baseline standard treatment. Patients were evaluated before and weekly after the intervention was initiated until complete cure. RESULTS: Overall, 82% of patients in group A, experienced complete cure and 9% of them had partial cure. On the other hand, 34% in group B reported complete cure, while 14% of them had partial cure at the end of treatment protocol with a significant difference between the two groups (P< 0.001). The mean duration to healing of the lesions in patients who received J. excelsa extract was statistically significantly shorter than the placebo group (p = 0.04). No significant side effect was seen in the J. excelsa extract group except for mild to moderate local irritation after a few weeks in a few numbers of patients. CONCLUSION: The results of this study showed that topical J. excelsa extract can be used as an adjuvant treatment modality in addition to cryotherapy for accelerating the time to cure in addition to increasing the complete cure rate in CL. TRIAL REGISTRATION: ClinicalTrials.gov IRCT2015082523753N1.


Assuntos
Antiprotozoários/uso terapêutico , Crioterapia/métodos , Juniperus/química , Leishmania/efeitos dos fármacos , Leishmaniose Cutânea/terapia , Extratos Vegetais/uso terapêutico , Administração Tópica , Adulto , África do Norte , Idoso , Terapia Combinada , Feminino , Flavonoides/análise , Humanos , Leishmania/classificação , Masculino , Pessoa de Meia-Idade , Oriente Médio , Óleos Voláteis/análise , Fenóis/análise , Placebos , Folhas de Planta/química , Resultado do Tratamento , Adulto Jovem
11.
J Educ Health Promot ; 6: 110, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29296611

RESUMO

INTRODUCTION: Some skin diseases are incurable and modern medicine can only control them. In addition, alternative treatment remedies including balneotherapy can be effective in improving skin conditions. However, there are only a limited number of studies on particular mineral or trace elements of mineral sources that have been identified in Iran. In this respect, the amount of minerals and trace elements in Mamasani thermal source, Fars Province, Iran, was measured using electrochemical, titration, and spectrophotometric methods and evaluated. MATERIALS AND METHODS: The amount of minerals and trace elements in Mamasani thermal source, Fars Province, Iran, was measured using electrochemical, titration, and spectrophotometric methods. RESULTS: The concentrations of natural gases such as H2S and NO3 in Mamasani thermal source were measured to be 22.10 mg/L and 42.79 mg/L, respectively. The source also contained major ions such as chloride, sulfate, sodium, calcium, magnesium, potassium, and carbonate. Due to the high concentration of chloride, sulfate, and sodium ions in comparison with other major ions, the water source is also classified as sulfide water. The existing trace elements in this thermal water source are iron, zinc, copper, selenium, cobalt, chromium, boron, silisium, aluminum, magnesium, and molybdenum. CONCLUSION: We concluded that bathing in this source could be beneficial. As nitrate concentration is close to the highest standard concentration for drinking water, it can be used in chronic dermatitis, psoriasis, burns, and allergy. Furthermore, the antibacterial and antifungal effects of sulfur-containing water in this source can be helpful in the treatment of leg ulcers, tinea versicolor, tinea corporis, and tinea capitis.

13.
Ann Hematol ; 89(10): 993-1001, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20440503

RESUMO

The present study aimed to define the natural history, World Health Organization (WHO) classification, prognostic factors, and treatment outcome of 87 patients with primary lymphoma of the palatine tonsil and literature review and analysis. Between 1990 and March 2008, 87 consecutive patients diagnosed with primary lymphoid malignancy of the palatine tonsil. All pathologic specimens were reviewed and reclassified according to the recent WHO classification. To investigate the association of tonsillar lymphomas with Epstein-Barr virus (EBV), in situ hybridization was performed for 24 tonsillar lymphomas (23 diffuse large B-cell lymphoma (DLBC) and one classic Hodgkin's disease) and ten normal tonsils as control group. In literature review, we found 26 major related series including 1,602 patients with primary tonsillar lymphoma. The median age of our patients was 52 years (range 11-86 years). There were 39 women and 48 men with a median follow-up of 67 months for living patients. The vast majority (95%) of patients had B-cell phenotype. DLBC was the most frequent histology. In situ hybridization revealed none of 23 DLBC to be positive for EBV. The 5-year disease-free and overall survival rates were 78.9% and 86%, respectively. In the literature review and by analyzing the data collection from 26 major reported series, the median age was 55 years and male/female ratio was 1.3:1. Intermediate grade tumors consisted of 72% of all tonsillar lymphomas and B-cell lymphomas constituted 82% of all cell immunophenotypes. The 5-year disease-free and overall survival rates were 61% and 67%, respectively. The vast majority of tonsillar lymphomas are of B-cell origin and with intermediate to high-grade histology. These neoplasms tend to present in early stage disease and to have favorable outcome. WHO classification predicts more accurately treatment outcome of patients with tonsillar lymphoma. The association of DLBC in the palatine tonsil with EBV infection is infrequent.


Assuntos
Linfoma Difuso de Grandes Células B/patologia , Neoplasias Tonsilares/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Infecções por Vírus Epstein-Barr/patologia , Feminino , Herpesvirus Humano 4/genética , Humanos , Imunofenotipagem , Linfoma Difuso de Grandes Células B/classificação , Linfoma Difuso de Grandes Células B/terapia , Linfoma Difuso de Grandes Células B/virologia , Masculino , Pessoa de Meia-Idade , Prognóstico , Taxa de Sobrevida , Neoplasias Tonsilares/classificação , Neoplasias Tonsilares/terapia , Neoplasias Tonsilares/virologia , Resultado do Tratamento , Organização Mundial da Saúde , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA